Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs

20251 citationsJournal Articlediamond Open Access

Authors

Bradley S. Wahle · MRIGlobal

Peter Pushko · Medigen (United States)

Katie A. Albanese · Battelle

Dylan M. Johnson · Sandia National Laboratories California

Irina Tretyakova · Medigen (United States)

Igor S. Lukashevich · University of Louisville

Thomas L. Rudge ·

Abstract

(4)Overall, this single-dose vaccine was locally and systemically well tolerated even after a two-dose repeat administration, confirming the high level of safety of ML29-SF vaccination and supporting the future evaluation of this LASV vaccine, including in clinical trials.

Topics & Keywords

Bacillus and Francisella bacterial research Hepatitis B Virus Studies Viral Infections and Outbreaks Research

Publication Details

Published in: Future Pharmacology

Volume 5, Issue 2, pp. 26-26

DOI: 10.3390/futurepharmacol5020026

Field-Weighted Citation Impact: 0.84

Command Palette

Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs

Authors

Abstract

Topics & Keywords

Publication Details